[Cellular therapy of diabetes: focus on the latest developments]

Area of Science:

• Endocrinology
• Stem Cell Biology
• Regenerative Medicine

Background:

• Islet transplantation is a foundational diabetes cell therapy.
• Human pluripotent stem cells show promise for beta-cell replacement but carry tumor formation risks.
• Adult pancreas progenitors are explored for beta-cell engineering.

Purpose of the Study:

• To review the latest developments in protocols for de novo production of functional beta cells.

Main Methods:

• Review of current research on stem cell differentiation and adult progenitor cell expansion.
• Analysis of strategies for in vivo and in vitro beta-cell engineering.

Main Results:

• Human pluripotent stem cells can differentiate into cells with near-normal beta-cell features.
• These stem cell-derived cells can reverse diabetes in mouse models.
• Tumorigenicity of stem cell-derived beta cells remains an unresolved challenge.

Conclusions:

• Ongoing research focuses on improving clinical outcomes for diabetes cell therapy.
• Both stem cells and adult pancreas progenitors are key areas for future beta-cell replacement strategies.
• Developing safe and effective methods for functional beta-cell production is critical.